OnlineMedEd Announces New Chief Executive Officer
Online healthcare curriculum company will expand to new healthcare markets and plans to accelerate growth with new funding round
Doug Hughes, CEO, …
Read More
Author: Purple Foxy
Over 20 Million Suffer From Peripheral Neuropathy, St. Pete Medical Group Aims to Help
ST. PETE MEDICAL GROUP Logo for ST. PETE MEDICAL GROUP
ST. PETERSBURG, Fla. – December 14, 2022 – (Newswire.com)
…
Innovative Soft Tissue Healing Treatments Now Available for Chronic Pain Sufferers in Virginia and Mid-Atlantic Region
The sam®x1 wireless sustained acoustic medicine device helps sports and regenerative medicine providers return their patients to everyday activities.
…
Read More
Shane McNamee of Smile Digital Health Named 2023 FedHealthIT100 Award Recipient
Smile Digital Health Celebrates Dr. Shane McNamee’s Recent Achievement
Smile Digital Health
logo
TORONTO – December 14, 2022 – (Newswire.com)
Smile Digital Health, a leading health data fabric and exchange platform, is proud to announce that Dr. Shane McNamee, Senior Vice President, Strategic Growth, Smile Digital Health, has been named as a 2023 FedHealthIT100 Award Winner.
This distinguished award honors 100 individuals recognized for driving change and advancement in the Federal Health Information Technology and Consulting Market.
Dr. McNamee has more than 15 years of experience overseeing the development and implementation of interoperability tools on various healthcare and technology teams, including large complex US Public Sector and commercial sector healthcare organizations.
Prior to joining Smile Digital Health, Dr. McNamee served in the Department of Veterans Affairs, spending years supporting the physical and psychological issues of severely combat-wounded and combat-exposed veterans. He also led VA and DoD data interoperability success in the Joint Legacy Viewer, helping to connect patient information across the federal landscape and was responsible for Fed Health IT systems integration at Peraton as CMIO.
This is not the first time Dr. McNamee has been recognized. In 2022, he was also a recipient of this prestigious award, showing that he continues to push towards digital transformation in the healthcare industry. He raises awareness in the community through informative articles, discussions and speaking engagements.
In the past year at Smile Digital Health, Dr. McNamee helped establish the company’s global market presence by powering product strategy, applied data to drive healthcare metrics, accelerated sales through business development, and built partnerships, alliances and distribution channels.
Along with these achievements, Dr. McNamee serves as the Executive Director for OMG® sponsored BPM+ Health Community and is a board member in IHE USA.
“We are beyond proud of our team’s thought leadership. This award is a recognition of Shane’s recent achievements and showcases those values that we, as an organization, strive towards,” said Duncan Weatherston, Chief Executive Officer, Smile Digital Health.
FedHealthIT is a trusted content provider, connecting government and industry through their FedHealthIT magazine and website.
“It is inspiring to see this year’s list of winners, selected by a panel of current and former government and industry leaders from across the Federal Health IT sector. The work they have contributed to the industry is immense. We look forward to seeing how these efforts impact future transformations in the field,” said Susan Sharer, Chief Executive Officer, FedHealthIT.
The recipients were honored at the 7th Annual FedHealthIT100 Awards and Holiday Celebration on Wednesday, Dec. 7. The conference brought together senior healthcare executives from across the Federal Government and industry to focus on The Year Ahead, including the initiatives and programs that will be driving Federal Health IT in 2023.
About the FedHealthIT100
The FedHealthIT100 is an annual award honoring individuals who are making an impact, going above and beyond, driving innovation and positive outcomes, challenging conventional wisdom, and giving back to the larger HealthIT community. For further information, visit https://www.fedhealthit.com
About Smile Digital Health
Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, health data fabric and exchange platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate, and meaningfully share health information to power digital transformation. We prepare healthcare providers, payers, researchers, and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes.
We help healthcare organizations confidently #ChooseOpenStandards with the goal of #BetterGlobalHealth. For more information, visit SmileDigitalHealth.com.
Contact Information:
Victoria Valladolid
Acting Director of Marketing
(877) 537-3343 x 728
Press Release Service
by
Newswire.com
Original Source:
Shane McNamee of Smile Digital Health Named 2023 FedHealthIT100 Award Recipient
Form Bio Brings Accelerated Genomic Analysis to Bioinformatics with NVIDIA Clara Parabricks
New Integration Delivers 52% Cost Savings and 88% Time Savings in Computational Execution with GPU-accelerated Industry-Standard Tools
…
Read More
Minicarm.com Expands Their Operations With Their New Mini C-Arm Refurbishment Center
Award-winning company expands their U.S. warehouse with its high-quality Mini C-Arm refurbishment center.
HAUPPAUGE, N.Y. …
Read More
CfPIE Introduces New Course on Ethics in Medical Research
Two-day virtual training session will give participants the skills to identify and address ethical challenges
MALVERN, Pa. …
Read More
Cambridge Biotherapies Opening New Mental Health Treatment Center Offering Psychedelic Therapy, TMS, and More in Amherst, Massachusetts
AMHERST, Mass. – December 13, 2022 – (Newswire.com)
Cambridge Biotherapies, the Boston area’s preeminent mental health care clinic, announced the opening of a new location in Amherst, Massachusetts. The announcement comes with great excitement. Cambridge Biotherapies’ medical director, Dr. Dan Brenner, explains, “We’ve looked forward to expanding what we offer to Amherst for a couple of years. Amherst is a diverse, inclusive community with so many educational and cultural opportunities.”
Cambridge Biotherapies leads the way in alternative, evidence-based treatments like psychedelic therapy (ketamine-assisted psychotherapy), ketamine infusion therapy, and TMS. “These are groundbreaking treatments for depression and anxiety,” according to Brenner. “They work faster than any interventions we have developed in psychiatry thus far – they are more effective, and they are generally safer than most medications.” With rigorously researched methods, Cambridge Biotherapies has kept up with cutting-edge scientific advancements in mental health care. “We’re delighted to bring these proven therapies to the Amherst area.” Cambridge Biotherapies also offers psychiatric medication management.
At Cambridge Biotherapies, we improve the lives of people affected by mental illness.
We pursue this mission by:
- Helping patients define and achieve recovery.
- Providing the highest-quality, compassionate care in collaboration with our patients, their families when needed, and outside treaters.
- Practicing with integrity, compassion, and discretion.
- Using evidenced-based treatments and staying fully up-to-date with emerging research.
- Maintaining the highest ethical standards.
- Focusing on our patients’ needs and tailoring treatment to meet each individual’s needs.
About Cambridge Biotherapies,
Many people find Cambridge Biotherapies at a critical time in their life.
Cambridge Biotherapies is a treatment-to-wellness center. We use ketamine therapy, ketamine-assisted psychotherapy, TMS, and medication management to address many mental health conditions. Our service begins with a full evaluation to determine the best way to treat each patient. This may involve single or multiple treatments for an integrated approach to wellness. Our job is not done until our patients recover.
Hospitals often feel cold and impersonal, but Cambridge Biotherapies fuses the latest technology and research with a comfortable, home-like environment. Our treatments are conducted by one clinician with one patient at a time, giving you privacy and an opportunity to engage in a safe and supportive relationship.
Dr. Daniel Brenner, Medical Director: Dr. Brenner attended Harvard University and Tufts Medical School. He completed his residency in Psychiatry at Cambridge Hospital, Harvard Medical School, where he served as Chief Resident. He then served as an Attending Psychiatrist and Fellow in the Program for Psychotherapy. He was a Clinical Instructor in Psychiatry at Harvard Medical School from 2000-2010 and is a Boston Psychoanalytic Society and Institute graduate. He was board certified in Psychiatry and Neurology and has been in private practice for over 20 years.
For questions or more information on the services that Cambridge Biotherapies offers, please contact them below:
7 N Pleasant St. Suite 2C Amherst, MA 01002
Phone: (617) 803-9722
Fax: (617) 812-1680
info@cambridgebiotherapies.com
Contact Information:
Brendan O’Connor
VP of Operations
brendan.oconnor@cambridgebiotherapies.com
617-803-9722
Press Release Service
by
Newswire.com
Original Source:
Cambridge Biotherapies Opening New Mental Health Treatment Center Offering Psychedelic Therapy, TMS, and More in Amherst, Massachusetts